Xtant Medical Holdings, Inc.

Total Valuation

Xtant Medical Holdings, Inc. carries a market capitalization of 52.60M, placing it among publicly traded companies globally. Its enterprise value stands at 75.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Xtant Medical Holdings, Inc. currently has 140.26M shares outstanding.

Valuation Ratios

Xtant Medical Holdings, Inc. trades at a trailing price-to-earnings ratio of 103.42. The price-to-sales ratio is 0.54, and the price-to-book ratio stands at 1.48.

Enterprise Valuation

On an enterprise value basis, Xtant Medical Holdings, Inc. trades at an EV/EBITDA multiple of 30.28 and an EV/FCF ratio of 14.55. The EV/Sales ratio of 0.69 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 59.17 provides insight into valuation relative to core operating earnings.

Financial Position

Xtant Medical Holdings, Inc. maintains a current ratio of 2.16, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 65.01, indicating elevated leverage, while an interest coverage ratio of -0.53 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Xtant Medical Holdings, Inc. has paid 1.90M in income taxes, reflecting an effective tax rate of 112.85.

Stock Price Statistics

Xtant Medical Holdings, Inc.'s stock has declined approximately -38.80548% over the past 52 weeks. The 50-day moving average sits at 0.40, while the 200-day moving average is 0.53.

Income Statement

Over the trailing twelve months, Xtant Medical Holdings, Inc. generated 109.53M in revenue and converted that into -11.14M in net income, yielding earnings per share of -0.08. EBITDA reached -1.47M, while operating income came in at -5.49M.

Balance Sheet

Xtant Medical Holdings, Inc. holds 9.87M in cash and equivalents against 26.01M in total debt, resulting in a net debt position of 13.12M. Total book value stands at 40.02M, with working capital of 34.81M providing operational flexibility.

Cash Flow

Xtant Medical Holdings, Inc. produced 570,000.00 in operating cash flow over the past twelve months. After subtracting -1.27M in capital expenditures, free cash flow totaled -696,000.00 - equivalent to 0.00 per share.

Margins

Xtant Medical Holdings, Inc. operates with a gross margin of 59.39, reflecting its pricing power and cost economics. The operating margin of -5.02 and net profit margin of -10.17 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Xtant Medical Holdings, Inc.'s most recent stock split took place on February 14, 2018 with a 12:1 split ratio.

Scores

Xtant Medical Holdings, Inc. posts an Altman Z-Score of -2.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.